Benefit of G-CSF for methotrexate-induced neutropenia in rheumatoid arthritis

A case in which recombinant granulocyte colony-stimulating factor was successfully used as treatment for severe neutropenia in a patient with rheumatoid arthritis receiving low-dose pulse methotrexate who had developed renal insufficiency is discussed.

Saved in:
Bibliographic Details
Published inThe American journal of medicine Vol. 92; no. 3; pp. 337 - 338
Main Authors Ellman, Michael H., Telfer, Margaret C., Turner, Arnold F.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.1992
Elsevier Sequoia S.A
Subjects
Arthritis
Arthritis, Rheumatoid - drug therapy
Blood
Drugs
Female
Granulocyte Colony-Stimulating Factor - therapeutic use
Humans
Kidneys
Methotrexate - adverse effects
Middle Aged
Neutropenia - chemically induced
Neutropenia - therapy
Online AccessGet full text

Cover

More Information
Summary:A case in which recombinant granulocyte colony-stimulating factor was successfully used as treatment for severe neutropenia in a patient with rheumatoid arthritis receiving low-dose pulse methotrexate who had developed renal insufficiency is discussed.
ISSN:0002-9343
1555-7162
DOI:10.1016/0002-9343(92)90088-S